Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.

MLA

Calzas, Cynthia, et al. “Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.” Frontiers in Immunology, vol. 12, Nov. 2021, p. 772550. EBSCOhost, https://doi.org/10.3389/fimmu.2021.772550.

APA

Calzas, C., Mao, M., Turpaud, M., Viboud, Q., Mettier, J., Figueroa, T., Bessière, P., Mangin, A., Sedano, L., Hervé, P.-L., Volmer, R., Ducatez, M. F., Bourgault, S., Archambault, D., Le Goffic, R., & Chevalier, C. (2021). Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens. Frontiers in Immunology, 12, 772550. https://doi.org/10.3389/fimmu.2021.772550

Chicago

Calzas, Cynthia, Molida Mao, Mathilde Turpaud, Quentin Viboud, Joelle Mettier, Thomas Figueroa, Pierre Bessière, et al. 2021. “Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.” Frontiers in Immunology 12 (November): 772550. doi:10.3389/fimmu.2021.772550.